ScoutQuest5 Oct 2026
Sudeep Pharma544619CEO role change

MD of wholly owned US subsidiary ceases to be Senior Management Personnel w.e.f. 2nd October 2026

Mr. Sendhil Pani, 'Managing Director' of Sudeep Pharma USA Inc. (a wholly owned subsidiary), has ceased to be a Senior Management Personnel (SMP) of the Company w.e.f. 2nd October 2026.

Person
Mr. Sendhil Pani
Designation
'Managing Director' of Sudeep Pharma USA Inc. (a wholly owned subsidiary)
Date of cessation as SMP
2nd October 2026
Reason for change
completion of contractual arrangements between the Company and Mr. Sendhil Pani

Who has changed

Why the change happened

The details shared in the annexure

How a retail investor can read this

Source: BSE · 5 Oct 2026

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.